SVA [SINOVAC BIOTECH] 6-K: Sinovac Enters into Amendment to Amalgamation Agreement for

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-04-27
Original SEC Filing: Click here


Webplus: SVA/20180427/6-K/2_EX-99.1/000.htm SEC Original: tv492327_ex99-1.htm
Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction Under the terms of the Amalgamation Agreement, the Amalgamation Agreement may be terminated by the Company or Parent if the amalgamation of Amalgamation Sub with and into the Company (the “Amalgamation”) has not occurred on or before April 26, 2018 (the “Termination Date”). The Amendment extends the Termination Date to




Webplus: SVA/20180427/6-K/3_EX-99.2/000.htm SEC Original: tv492327_ex99-2.htm
EXECUTION COPY AMENDMENT NO. 2 TO THE AMALGAMATION AGREEMENT Amendment Parent Amalgamation Sub Company Party Parties AMENDMENT NO. 2 TO AMALGAMATION AGREEMENT (this “ Original Amalgamation Agreement Amalgamation WHEREAS, the Parties have entered into that certain Amalgamation Agreement, dated as of June 26, 2017 (the “ Amendment No. 1 Amalgamation Agreement WHEREAS, the Parties have entered into that certain Amendment




Webplus: SVA/20180427/6-K/1/000.htm SEC Original: tv492327_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-04-27CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085

Home Page Forums

By | 2018-04-27T13:07:25+00:00 April 27th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar